Efficacy and tolerability of abatacept treatment: results of 12 months observation von Borisova, M A, Lukina, G V, Sigidin, Y A, Aronova, E S, Luchihina, E L, Karateev, D E, Glukhova, S V, Nasonov, E L

Volltext

Association of polymorphisms of HLA-DRB1 and TNF-308 G/A with radiographic joint damage in patients with early rheumatoid arthritis with high inflammatory activity, treated accordi... von Guseva, I A, Smirnov, A V, Demidova, N V, Krylov, M Yu, Avdeeva, A S, Samarkina, E Yu, Luchikhina, E L, Karateev, D E, Abramov, D D, Nasonov, E L

Volltext

The prevalence and factors associated with coronary heart disease in patients with gout von Markelova, E. I., Eliseev, M. S., Ilinykh, E. V., Karateev, D. E., Gluhova, S. I., Nasonov, E. L.

Volltext

Immunomodulatory drug therapy for the disease caused by SARS-CoV-2 infection (COVID-19) von Karateev, D. E., Luchikhina, E. L.

Volltext

The role of targeted synthetic drugs in the treatment of rheumatic diseases: focus on tofacitinib von Karateev, D. E., Luchikhina, E. L.

Volltext

Inhibitor of biological effects of interleukin-6 sarilumab in treatment of rheumatoid arthritis von Karateev, D. E., Luchikhina, E. L.

Volltext

New possibilities of drug therapy for rheumatoid arthritis: focus at sarilumab von Karateev, D. E., Luchikhina, E. L.

Volltext

How should a patient with rheumatoid arthritis behave after achievement of remission? von Karateev, D. E.

Volltext

Golimumab in the treatment of inflammatory diseases: A role of immunogenicity von Karateev, D. E.

Volltext

EU Registries Forum Meeting is a new step in the development of international cooperation in rheumatic diseases registries von Karateev, D. E.

Volltext

Comorbidities and predicting the outcome of COVID-19: the treatment results of 13,585 patients hospitalized in the Moscow Region von Molochkov, A. V., Karateev, D. E., Ogneva, E. Yu, Zulkarnaev, A. B., Luchikhina, E. L., Makarova, I. V., Semenov, D. Yu

Volltext

Treatment strategy for rheumatoid arthritis: hot topics von Karateev, D. E.

Volltext

PAIN AND INFLAMMATION. PART 2. THE ANALGESIC POTENTIAL OF ANTI-INFLAMMATORY DRUGS von Karateev, A. E., Karateev, D. E., Davydov, O. S.

Volltext

PAIN AND INFLAMMATION. PART 1. PATHOGENETIC ASPECTS von Karateev, A. E., Karateev, D. E., Davydov, O. S.

Volltext

Minor rheumatology: Nonsystemic rheumatic disease of juxta-articular soft tissues of the pelvis and lower extremity: Diagnosis and treatment. Part 3 von Karateev, A. E., Karateev, D. E.

Volltext

The use of subcutaneous methotrexate from various manufacturers in real clinical practice: a comparative study von Karateev, D. E., Luchikhina, E. L., Gridneva, G. I., Demidova, N. V.

Volltext

LEFLUNOMIDE IN EARLY RHEUMATOID ARTHRITIS: INCLUSION IN THE TREATMENT STRATEGY AND PROSPECTS von D. E. Karateev, E. V. Orlova

Volltext

MODERN PRINCIPLES OF MANAGEMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS von D. E. Karateev, E. L. Luchikhina

Volltext

Minor rheumatology: Nonsystemic rheumatic disease of juxta-articular soft tissues of the upper extremity. Part 2. Drug and non-drug treatments von Karateev, Andrei Evgenyevich, Karateev, D. E., Ermakova, Yu. A.

Volltext

FRI0121 Treat to target strategy in early rheumatoid arthritis: necessity of achieving tight control of disease and aggressive monitoring of cardiovascular risk von Novikova, D. S., Gorbunova, Y. N., Popkova, T. V., Markelova, E. I., Karateev, D. E., Nasonov, E. L.

Volltext